Commercial Vehicle Group, Inc. — Q3 2012 Form 10-Q
Reporting period: Three and nine months ended September 30, 2012. Financial statements are unaudited; amounts below are in millions except per-share data.
Business context
CVG designs and manufactures cab-related products and systems for commercial vehicles, including heavy-duty trucks, construction equipment, buses, agriculture, military and specialty transportation. Demand is cyclical and depends on vehicle production, economic conditions, customer inventory and production decisions, and regulation.
Financial performance
| Metric | Q3 2012 | Q3 2011 | Nine months 2012 | Nine months 2011 |
|---|---|---|---|---|
| Revenue | $204.8 | $216.9 | $684.6 | $606.2 |
| Gross profit / margin | $26.4 / 12.9% | $29.8 / 13.7% | $100.6 / 14.7% | $82.2 / 13.6% |
| Operating income / margin | $8.9 / 4.4% | $13.5 / 6.2% | $46.4 / 6.8% | $33.0 / 5.4% |
| Net income | $30.5 | $7.4 | $55.6 | $8.5 |
| Diluted EPS | $1.07 | $0.26 | $1.96 | $0.30 |
| Operating cash flow | Not separately presented for the quarter | $24.3 | $(1.7) |
- Q3 performance weakened operationally: Revenue fell 5.6%, primarily due to lower North American heavy-duty truck production, lower production in Europe, Australia and Asia, and unfavorable currency translation. Gross margin declined 0.8 percentage points; operating income fell about 34% as SG&A rose 7.6%.
- Nine-month growth: Revenue rose 12.9%, with management attributing approximately $84.6 million of the increase to higher North American Class 8 production, other North American end markets and new business awards. Gross margin improved 1.1 percentage points.
- Tax benefit materially lifted reported earnings: The Q3 income tax benefit was $26.9 million, versus an $0.8 million provision a year earlier. CVG reversed domestic deferred-tax valuation allowances; it recorded a $29.4 million benefit in Q3, within a total $53.5 million reversal of allowances existing at year-end 2011. Accordingly, net income and EPS are not representative of operating performance alone.
- For the nine months, interest and other expense was $15.9 million, versus $14.4 million. The 2011 comparison included a $7.4 million loss on early debt extinguishment; there was no such charge in 2012.
Financial position and liquidity
- At September 30, cash was $99.5 million, up from $88.0 million at December 31, 2011; current assets were $338.5 million and current liabilities $110.7 million.
- Long-term debt was $250.0 million, consisting of 7.875% senior secured notes due 2019. Cash less debt was approximately $150.5 million. The notes’ estimated fair value was $256.3 million.
- The $40.0 million asset-based revolver had no borrowings, approximately $3.0 million of letters of credit and $37.0 million of availability. The facility matures April 2014. CVG reported covenant compliance and no default; the fixed-charge coverage test was not required while availability remained above $10.0 million.
- Nine-month cash flow: operating activities provided $24.3 million; investing activities used $14.0 million, primarily capital expenditures of $13.1 million; financing activities had no net cash flow. Cash increased $11.6 million, including a $1.3 million favorable currency effect.
- Inventories rose to $90.7 million from $79.4 million at year-end, reflecting higher production levels. Approximately $36.1 million of cash was held by foreign subsidiaries; repatriation could incur taxes, and CVG said it intended to use these funds to support foreign operations.
Outlook, risks and unusual items
- CVG gave no specific company revenue or earnings guidance. Management said its forecast indicated available cash, operating cash flow and revolver borrowings should fund anticipated working capital, capital spending, strategic initiatives and debt service for the next 12 months, while cautioning that there can be no assurance.
- An October 2012 ACT Research industry forecast cited by CVG projected North American Class 8 production rising from 255,000 in 2011 to a peak of 308,000 in 2014, then declining to 236,000 in 2016. This is an external industry forecast, not company guidance.
- Key risks include commercial-vehicle cyclicality, foreign currency and international operations, competition, customer or platform losses, regulation, new-product execution, financing availability and revolver covenant compliance. Management noted that economic or business conditions outside its control could affect future covenant compliance.
- CVG maintains a $3.1 million warranty liability. It disclosed ordinary-course legal matters, but no material litigation; management said it did not expect the overall outcome of incidental claims to materially affect results, while noting outcomes are uncertain.
- Tax matters include $1.1 million of unrecognized tax benefits and ongoing examinations. CVG continued valuation allowances against certain foreign deferred tax assets, including $8.3 million for the U.K.; continued U.K. profitability could potentially support a future release. Management reported disclosure controls were effective at quarter-end and no material change in internal control.
Important facts for investors to verify
- How much of reported earnings and EPS growth reflects the deferred-tax valuation-allowance release rather than recurring operations.
- Whether weaker Q3 revenue and operating margins persist, and how production trends, geographic mix, new awards and SG&A affect profitability.
- Whether operating cash generation can sustain working-capital needs, capital expenditures and $250.0 million of debt service, particularly as inventory increases.
- Revolver availability, covenant headroom and compliance as operating conditions change; the facility matures in April 2014.
- Developments in tax examinations, unrecognized tax benefits and foreign valuation allowances, as well as warranty claims and other contingencies.